SK bioscience

본문바로가기

KOR ENG

sitemap

PR

SK bioscience company news updates

Press Releases

SK bioscience Launches Influenza Vaccination Campaign Ahead of Flu Season “Get Vaccinated Before the Chuseok Holiday to Protect Your Family’s Health”

2025.09.29
SK bioscience Submits IND for Phase 3 Clinical Trial of 2-Dose Varicella Vaccine

2025.09.02
SK bioscience Successfully Concludes Nationwide Symposium Series on RSV Preventive Antibody ‘Beyfortus’

2025.08.29
SK Group Chairman Taewon Chey and Bill Gates to Strengthen Cooperation in Energy and Biotechnology

2025.08.22
SK bioscience Discusses Collaboration with the Gates Foundation to Advance Global Health

2025.08.21
SK bioscience Launches RSV Awareness Campaign at BeFe Baby Fair

2025.08.14
SK bioscience Releases 2025 ESG Report

2025.07.22
SK bioscience Receives Approval for Clinical Trials of 21-valent Pneumococcal Vaccine Candidate in China

2025.07.18
SK bioscience Submits IND for Phase 1/2 Clinical Trial of Adjuvanted Influenza Vaccine Candidate

2025.07.17
SK bioscience Celebrates Completion of New Vaccine Production Facility for Global Market, Advancing Partnership with Sanofi

2025.06.30
SK bioscience Strengthens ESG Commitment through Invasive Plant Removal Activities

2025.06.17
SK bioscience Expands Manufacturing Facility to Boost Global Vaccine Supply

2025.05.29